Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure

This study has been terminated.
(Funding ceased)
Sponsor:
Collaborators:
Heart and Stroke Foundation of Ontario
LEO Pharma
Information provided by (Responsible Party):
Wendy Lim, St. Joseph's Healthcare Hamilton
ClinicalTrials.gov Identifier:
NCT00186745
First received: September 13, 2005
Last updated: April 18, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2016
  Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)